search
Back to results

Acupuncture for Chronic Low Back Pain in Older Adults (BackInAction)

Primary Purpose

Chronic Low-back Pain

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Standard Acupuncture
Enhanced Acupuncture
Sponsored by
Kaiser Permanente
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Low-back Pain focused on measuring Chronic Low-back Pain, Acupuncture Therapy

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Is at least 65 years of age
  • Is a current member or patient of the healthcare system
  • Visited a health care provider for low back pain within the past 12 months
  • Received primary care at one of the participating health care systems
  • Has back pain that is uncomplicated with or without radicular pain
  • Back pain at least 3 months
  • General activity question from PEG (Pain, Pain Interference with Enjoyment, General Activity scale) at least 3
  • Primary care provider provides permission to contact patient
  • Willing and able to provide consent (Callahan cognitive impairment screener at least 3)

Exclusion Criteria:

  • Specific types of back pain (metastatic cancer or bone cancer or secondary cancers, vertebral fractures, spinal infection, active inflammatory disease)
  • Low back surgery within past 3 months
  • Receiving workers compensation or involved in litigation related to chronic low back pain
  • Acupuncture within the last 6 months
  • Does not speak or write English or Spanish
  • Major psychosis, dementia
  • Current cancer treatment
  • Red flags of serious underlying illness (a fever most days in the last month; recent unexplained weight loss of 10 lbs or more)
  • Living in a nursing home, on Hospice, or palliative care
  • Non-speaking deafness
  • Non-reliable transportation

Sites / Locations

  • Kaiser Permanente Division of Research
  • Sutter Health
  • Institute for Family Health
  • Kaiser Permanente Washington Health Research Institute

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

No Intervention

Arm Label

Standard Acupuncture

Enhanced Acupuncture

Usual Care

Arm Description

Participants randomized to standard acupuncture will receive 8-15 acupuncture treatments over 3 months.

Participants randomized to enhanced acupuncture will receive 12-21 acupuncture treatments over 6 months.

Participants assigned to the usual care arm will not receive acupuncture and will be asked to not get acupuncture over the one-year course of the study.

Outcomes

Primary Outcome Measures

Change in back-related disability at 6-month post randomization (continuous)
Change in back-related disability is defined as score change in Roland Morris Disability Questionnaire (RMDQ), a 24-item questionnaire which asked whether 24 specific activities were limited due to back pain during the past week. The RMDQ is scored from 0 to 24, with higher scores indicating more disability. Greater change between baseline and 6-months would indicate greater improvement.

Secondary Outcome Measures

Change in back-related disability at 3-, and 12-month (continuous)
Change in back-related disability is defined as score change in RMDQ, a 24-item questionnaire which asked whether 24 specific activities were limited due to back pain during the past week. The RMDQ is scored from 0 to 24, with higher scores indicating more disability. Greater change between baseline and 6-months would indicate greater improvement.
Achieving Minimal Clinically Important Difference (MCID) in back-related dysfunction at 3-, 6-, and 12-months (binary)
The MCID is measured by a 30% improvement (reduction) on the RMDQ. Because the MCID reflects clinical improvement, this measure indicates what proportion of individuals in each study group improved at least 30% at each follow-up timepoint on the RMDQ.
Change in Pain, Pain Interference with Enjoyment, General Activity (PEG) at 3-, 6- and 12-month (continuous)
Change in pain intensity and pain interference with enjoyment of life and general activity will be measured by PEG, a 3-item pain-intensity and pain-related interference composite measure assessing pain intensity, and pain interference with enjoyment of life and general activity. Each item is measured by a 0 to 10 scale with 10 indicating greater pain intensity or pain interference. The scores are then averaged with a higher average score indicating greater pain interference/intensity.
Achieving MCID in Pain, Pain Interference with Enjoyment, General Activity (PEG) at 3-, 6-, and 12-months (binary)
The MCID is measured by a 30% improvement (reduction) on the PEG. Because the MCID reflects clinical improvement, this measure indicates what proportion of individuals in each study group improved at least 30% for a particular follow-up timepoint on the PEG.
Change in physical functioning at 3-, 6- and 12-month (continuous)
Change in the Patient-Reported Outcomes Measurement and Information System (PROMIS) Physical functioning short form 6b from the PROMIS-29 (6 items). The 6-item Physical function scale measures self-reported ability to perform activities rather than the actual performance of those activities. Each question has five response options, ranging from one to five. Raw scores range from 6 to 30, with higher scores indicating greater ability. The scores are then standardized using a T-score metric in which 50 is the reference mean and 10 is the standard deviation (SD) of that population.
Patient global impression of change (PGIC) at 3-, 6-, and 12- months
Patient Global Impression of Change in Overall Pain (1 item). This is a 0 to 6 scale ranging from much worse to much better, with higher scores indicating more improvement.
Serious Adverse Effects (SAE)/non-Serious Adverse Effects (AE)
Serious Adverse Effects/non-Serious Adverse Effects attributed to acupuncture

Full Information

First Posted
July 1, 2021
Last Updated
June 13, 2023
Sponsor
Kaiser Permanente
Collaborators
National Center for Complementary and Integrative Health (NCCIH)
search

1. Study Identification

Unique Protocol Identification Number
NCT04982315
Brief Title
Acupuncture for Chronic Low Back Pain in Older Adults
Acronym
BackInAction
Official Title
Pragmatic Trial of Acupuncture for Chronic Low Back Pain in Older Adults
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
August 12, 2021 (Actual)
Primary Completion Date
May 12, 2023 (Actual)
Study Completion Date
October 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Kaiser Permanente
Collaborators
National Center for Complementary and Integrative Health (NCCIH)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The main goal of the BackInAction research study is to determine the effectiveness of a standard course of acupuncture (15 sessions of acupuncture over 3 months) and an enhanced course of acupuncture (an additional 6 sessions of acupuncture over months 4-6) in improving back-related disability in older adults (65+ years) with chronic low back pain compared to usual care alone. Key secondary aims are to determine the effectiveness of acupuncture in improving a composite score of pain intensity and pain interference.
Detailed Description
Background: A critical gap exists in evidence regarding the safety and effectiveness of treatments for older adults (65+ years) with chronic low back pain. Acupuncture has been found to be effective in treating chronic low back pain in younger adults. Yet trials have rarely included older adults, who have more comorbidities and may respond differently than typical trial participants. BackInAction has been designed to address this gap. Purpose: The main goal of BackInAction is to evaluate the effectiveness of a standard course of acupuncture (up to 15 sessions of acupuncture over 3 months) and an enhanced course of acupuncture (up to an additional 6 sessions of acupuncture over months 4-6) in improving back-related disability in older adults with chronic low back pain compared to usual care alone. Key secondary aims are to determine the effectiveness of acupuncture in improving a composite score of pain intensity and pain interference. Design and Outcomes: In this pragmatic, three-arm parallel groups multi-site randomized controlled trial, the investigators will recruit and randomize at least 789 adults ≥ 65 years of age with chronic low back to standard acupuncture, enhanced acupuncture, or usual medical care alone in four health-care systems. These include two integrated health care systems, a fee-for-service system and a network of federally qualified health centers. Primary outcome data will be collected by questionnaire at 3-, 6-, and 12-months post-randomization. In addition, short monthly surveys will capture data on physical function and a composite score of pain intensity and pain interference. Interventions and Duration: Standard acupuncture will consist of 3 months (90 days) of acupuncture needling, with a proposed minimum of 8 treatments and a maximum of 15. Enhanced acupuncture will include the standard acupuncture plus an additional 3-month maintenance period, with a maximum of six additional treatments. Usual medical care will consist of the care that individuals receive according to their insurance benefits plus anything else they pay for out of pocket. The investigators will ask those assigned to usual medical care to avoid acupuncture for the year they are enrolled in the study. Both active treatment arms will also have access to usual medical care. Participants will be enrolled in the study for 12 months. Sample Size and Population: BackInAction will include patients at least 65 years of age with uncomplicated chronic low back pain with or without radiculopathy. The investigators plan to enroll at least 789 participants (263 per study arm). Participants will be recruited from four health plans, with varying numbers of participants from each site. Randomization will be stratified by health care system, age category and gender. The investigators expect the racial and ethnic mix will roughly parallel that of the older Medicare population.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Low-back Pain
Keywords
Chronic Low-back Pain, Acupuncture Therapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
807 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard Acupuncture
Arm Type
Experimental
Arm Description
Participants randomized to standard acupuncture will receive 8-15 acupuncture treatments over 3 months.
Arm Title
Enhanced Acupuncture
Arm Type
Experimental
Arm Description
Participants randomized to enhanced acupuncture will receive 12-21 acupuncture treatments over 6 months.
Arm Title
Usual Care
Arm Type
No Intervention
Arm Description
Participants assigned to the usual care arm will not receive acupuncture and will be asked to not get acupuncture over the one-year course of the study.
Intervention Type
Procedure
Intervention Name(s)
Standard Acupuncture
Intervention Description
The standard acupuncture intervention is based on classical Chinese acupuncture therapy. Participants randomized to standard acupuncture will receive up to 15 acupuncture treatments over 3 months with the total number being determined by the patient and acupuncturist together. All treatments will include acupuncture needling only. They will be provided at medical facilities or in private acupuncturists' offices.
Intervention Type
Procedure
Intervention Name(s)
Enhanced Acupuncture
Intervention Description
The enhanced acupuncture intervention includes the 3 months of standard acupuncture plus an additional 3 months of maintenance acupuncture. Participants randomized to enhanced acupuncture will receive up to 21 acupuncture treatments over 6 months. The maintenance acupuncture treatment sessions are expected to consist of the same intervention used in the first 3 months of care described in the standard acupuncture arm, plus up to 6 treatments during the maintenance phase. All treatments will include acupuncture needling only. They will be provided at medical facilities or in private acupuncturists' offices.
Primary Outcome Measure Information:
Title
Change in back-related disability at 6-month post randomization (continuous)
Description
Change in back-related disability is defined as score change in Roland Morris Disability Questionnaire (RMDQ), a 24-item questionnaire which asked whether 24 specific activities were limited due to back pain during the past week. The RMDQ is scored from 0 to 24, with higher scores indicating more disability. Greater change between baseline and 6-months would indicate greater improvement.
Time Frame
Baseline to 6-month
Secondary Outcome Measure Information:
Title
Change in back-related disability at 3-, and 12-month (continuous)
Description
Change in back-related disability is defined as score change in RMDQ, a 24-item questionnaire which asked whether 24 specific activities were limited due to back pain during the past week. The RMDQ is scored from 0 to 24, with higher scores indicating more disability. Greater change between baseline and 6-months would indicate greater improvement.
Time Frame
Test of Standard Acupuncture: Baseline to 3 months; Test of Maintenance effect: Baseline to 12 months
Title
Achieving Minimal Clinically Important Difference (MCID) in back-related dysfunction at 3-, 6-, and 12-months (binary)
Description
The MCID is measured by a 30% improvement (reduction) on the RMDQ. Because the MCID reflects clinical improvement, this measure indicates what proportion of individuals in each study group improved at least 30% at each follow-up timepoint on the RMDQ.
Time Frame
Study primary outcome timepoint: Baseline to 6 months; Test of Standard Acupuncture: Baseline to 3 months; Test of Maintenance effect: Baseline to 12 months
Title
Change in Pain, Pain Interference with Enjoyment, General Activity (PEG) at 3-, 6- and 12-month (continuous)
Description
Change in pain intensity and pain interference with enjoyment of life and general activity will be measured by PEG, a 3-item pain-intensity and pain-related interference composite measure assessing pain intensity, and pain interference with enjoyment of life and general activity. Each item is measured by a 0 to 10 scale with 10 indicating greater pain intensity or pain interference. The scores are then averaged with a higher average score indicating greater pain interference/intensity.
Time Frame
Study primary outcome timepoint: Baseline to 6 months; Test of Standard Acupuncture: Baseline to 3 months; Test of Maintenance effect: Baseline to 12 months
Title
Achieving MCID in Pain, Pain Interference with Enjoyment, General Activity (PEG) at 3-, 6-, and 12-months (binary)
Description
The MCID is measured by a 30% improvement (reduction) on the PEG. Because the MCID reflects clinical improvement, this measure indicates what proportion of individuals in each study group improved at least 30% for a particular follow-up timepoint on the PEG.
Time Frame
Study primary outcome timepoint: Baseline to 6 months; Test of Standard Acupuncture: Baseline to 3 months; Test of Maintenance effect: Baseline to 12 months
Title
Change in physical functioning at 3-, 6- and 12-month (continuous)
Description
Change in the Patient-Reported Outcomes Measurement and Information System (PROMIS) Physical functioning short form 6b from the PROMIS-29 (6 items). The 6-item Physical function scale measures self-reported ability to perform activities rather than the actual performance of those activities. Each question has five response options, ranging from one to five. Raw scores range from 6 to 30, with higher scores indicating greater ability. The scores are then standardized using a T-score metric in which 50 is the reference mean and 10 is the standard deviation (SD) of that population.
Time Frame
Study primary outcome timepoint: Baseline to 6 months; Test of Standard Acupuncture: Baseline to 3 months; Test of Maintenance effect: Baseline to 12 months
Title
Patient global impression of change (PGIC) at 3-, 6-, and 12- months
Description
Patient Global Impression of Change in Overall Pain (1 item). This is a 0 to 6 scale ranging from much worse to much better, with higher scores indicating more improvement.
Time Frame
Study primary outcome timepoint: 6 months; Test of Standard Acupuncture: 3 months; Test of Maintenance effect: 12 months
Title
Serious Adverse Effects (SAE)/non-Serious Adverse Effects (AE)
Description
Serious Adverse Effects/non-Serious Adverse Effects attributed to acupuncture
Time Frame
SAE: 12 months from electronic health record data; AE: 12 months from acupuncture treatment records and follow-up interviews.
Other Pre-specified Outcome Measures:
Title
Change in sleep duration at 3-, 6- and 12-month and in sleep during at 6-months (continuous)
Description
Change in sleep quality will be measured by the 6-item subscale for sleep quality in the Patient-Reported Outcomes Measurement and Information System (PROMIS) and a 1-item sleep duration scale for sleep duration. For sleep quality, each item is measured by a 1 to 5 scale with 1 indicating greater sleep quality.
Time Frame
Study primary outcome timepoint: Baseline to 6 months (sleep quality and duration); Test of Standard Acupuncture: Baseline to 3 months (sleep duration only); Test of Maintenance effect: Baseline to 12 months (sleep duration only)
Title
Change in symptoms suggesting clinically relevant anxiety at 3-, 6- and 12-month (continuous)
Description
Change in PRO scores about the frequency of being anxious or having uncontrollable worry over the past two weeks from the GAD-2, which is part of the PHQ-4. Each item is measured by a 0 to 3 scale with 3 indicating greater anxiety.
Time Frame
Study primary outcome timepoint: Baseline to 6 months; Test of Standard Acupuncture: Baseline to 3 months; Test of Maintenance effect: Baseline to 12 months
Title
Change in symptoms suggesting depression at 3-, 6- and 12-month (continuous)
Description
Change in PRO scores about the frequency of depressed mood and anhedonia over the past two weeks from the PHQ-2. Each item is measured by a 0 to 3 scale with 3 indicating greater depression.
Time Frame
Study primary outcome timepoint: Baseline to 6 months; Test of Standard Acupuncture: Baseline to 3 months; Test of Maintenance effect: Baseline to 12 months
Title
Change in fatigue at 3-, 6- and 12-month (continuous)
Description
Change in fatigue will be measured by the 4-item subscale for fatigue in PROMIS. Each item is measured by a 1 to 5 scale with 5 indicating greater fatigue.
Time Frame
Study primary outcome timepoint: Baseline to 6 months; Test of Standard Acupuncture: Baseline to 3 months; Test of Maintenance effect: Baseline to 12 months
Title
Change in ability to engage in social roles at 3-, 6- and 12-month (continuous)
Description
Change in ability to engage in social roles will be measured by the 4-item subscale for ability to participate in social roles in PROMIS. Each item is measured by a 1 to 5 scale with 5 indicating greater ability to engage in social roles.
Time Frame
Study primary outcome timepoint: Baseline to 6 months; Test of Standard Acupuncture: Baseline to 3 months; Test of Maintenance effect: Baseline to 12 months
Title
Cost and incremental cost-effectiveness
Description
Health care utilization and intervention costs will be assessed. Our primary measure of effectiveness (utility) at 12 months will be quality-adjusted life years (QALYs) gained measured by the EQ-5D-5L. We will also estimate the incremental cost per additional patient with a MCID (30% from baseline) reduction in the RMDQ at 12 months. The RMDQ is scored from 0 to 24, with higher scores indicating more disability.
Time Frame
Patient health care utilization costs from baseline to 12 months net of their utilization from the previous 12 months. EQ-5D-5L: Patient self-report at baseline, 3-, 6- and 12-months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Is at least 65 years of age Is a current member or patient of the healthcare system Visited a health care provider for low back pain within the past 12 months Received primary care at one of the participating health care systems Has back pain that is uncomplicated with or without radicular pain Back pain at least 3 months General activity question from PEG (Pain, Pain Interference with Enjoyment, General Activity scale) at least 3 Primary care provider provides permission to contact patient Willing and able to provide consent (Callahan cognitive impairment screener at least 3) Exclusion Criteria: Specific types of back pain (metastatic cancer or bone cancer or secondary cancers, vertebral fractures, spinal infection, active inflammatory disease) Low back surgery within past 3 months Receiving workers compensation or involved in litigation related to chronic low back pain Acupuncture within the last 6 months Does not speak or write English or Spanish Major psychosis, dementia Current cancer treatment Red flags of serious underlying illness (a fever most days in the last month; recent unexplained weight loss of 10 lbs or more) Living in a nursing home, on Hospice, or palliative care Non-speaking deafness Non-reliable transportation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lynn L DeBar, PhD, MPH
Organizational Affiliation
Kaiser Permanente
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Andrea J Cook, PhD
Organizational Affiliation
Kaiser Permanente
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kaiser Permanente Division of Research
City
Oakland
State/Province
California
ZIP/Postal Code
94612
Country
United States
Facility Name
Sutter Health
City
Walnut Creek
State/Province
California
ZIP/Postal Code
94596
Country
United States
Facility Name
Institute for Family Health
City
New York
State/Province
New York
ZIP/Postal Code
10035
Country
United States
Facility Name
Kaiser Permanente Washington Health Research Institute
City
Seattle
State/Province
Washington
ZIP/Postal Code
98103
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The Kaiser Permanente Washington-based data coordinating center will produce a releasable de-identified database corresponding to the primary outcomes manuscript that can be used by research investigators outside of the study. This dataset will also include the NIH HEAL (Helping to End Addiction Long-term) Initiative common data elements collected from study participants. The dataset will be completely de-identified in accordance with the definitions provided in the Health Insurance Portability and Accountability Act and in accordance to the standards set forth in the Department of Health and Human Services Regulations for the Protection of Human Subjects. All identifiers specified in HIPAA will be recoded in a manner that will make it impossible to deduce or impute the specific identity of any patient. The database will not contain any institutional or healthcare system identifiers.
IPD Sharing Time Frame
The de-identified dataset will be released within 12 months of the publication of the primary manuscript.
IPD Sharing Access Criteria
Access to the de-identified database housed in an NIH-assigned repository will be in accordance with procedures and regulations of the NIH HEAL Initiative and the project funder (NCCIH). The project team does not plan to provide any support for investigators using the HEAL releasable database.
IPD Sharing URL
https://heal.nih.gov/about/public-access-data

Learn more about this trial

Acupuncture for Chronic Low Back Pain in Older Adults

We'll reach out to this number within 24 hrs